HENDERSON, NV / ACCESSWIRE / July 30, 2018 / Biotech companies that are advancing their research are the type of company that, smart investors are actively looking for.
One small cap biotech company that we have discovered BRTX (BioRestorative Therapies, Inc.). BRTX is on the cusp of receive major attention from the street. As BRTX prepares for it's Phase 2 clinical trial using BRTX-100 to treat chronic lumbar disc disease, the company is flying under the radar of most investors, which presents a great opportunity to investors that are currently in the know on BRTX. And the company just had very important, as well as favorable news which could lead to even more developments for the company. Keep BRTX on your radar because missing out on this very innovative and interesting company would be very disappointing.
Other Biotech firms that are advancing their own research and trade on a national exchange include: Nevro Corp. (NVRO), and Verastem, Inc. (NASDAQ: VSTM).
BioRestorative Therapies, Inc. (BRTX)
Market Cap: $10.57M Share Price: $1.59
BioRestorative Therapies, Inc. (BRTX), a life sciences company focused on stem cell-based therapies, recently announced the appointment of Jason S. Lipetz, M.D. to the Company's Scientific Advisory Board. Dr. Lipetz has an impressive resume and will certainly add clinical expertise as the Company prepares for its Phase 2 trial using BRTX-100 to treat chronic lumbar disc disease. So far the stock has been trading sideways, announcements like these many times lead to more news in the near future. Investors should monitor this situation closely.
Nevro Corp. (NVRO)
Market Cap: $62.64B Share Price: $55.86
Another company reporting this week is Nevro Corp. (NVRO). The company recently announced that it will release financial results for the second quarter of 2018 after market close this Thursday, August 2, 2018. Investors will be hoping for positive results after dealing with declining share value most of 2018.
Verastem, Inc. (VSTM)
Market Cap: $563.6M Share Price: $7.66
Investors in Verastem have been experiencing a much better year than Nevro Corp.'s. VSTM stock is on the upswing over the past six months. Earlier this month, Veristem announced the granting of stock options to nine new employees to purchase an aggregate of 201,500 shares of Verastem Oncology's common stock.
Legal Disclaimer
Except for the historical information presented herein, matters discussed in this article contain forward-looking statements that are subject to certain risks and uncertainties that could cause actual results to differ materially from any future results, performance or achievements expressed or implied by such statements. ACR Communication, LLC, which owns Microcapspeculators.com, is not registered with Finra or any other financial or securities regulatory authority, and does not provide nor claims to provide investment advice or recommendations to readers of this release. ACR Communication, LLC [and/or] Microcapspeculators.com does not have a position in the securities mentioned herein and may increase or decrease such positions without notice. For making specific investment decisions, readers should seek their own advice. ACR Communication LLC, which owns Microcapspeculators.com, is compensated for its services in the form of cash-based compensation or in equity in the companies it writes about, or a combination of the two. ACR Communication, LLC has been compensated one thousand dollars cash for this article and seven thousand dollars total by Regal Consulting. LLC, for news commentary articles for BRTX. BRTX and Regal Consulting, LLC were given an opportunity to edit information included in this article. This article is based solely on public information and the opinions of ACR Communication, LLC, which believes the news commentary to include accurate and complete information. ACR Communication, LLC, will not buy or sell any shares in stocks contained within this article for forty eight hours after this article's distribution.
For Full Legal Disclaimer Click Here.
Contact Information:
Company Name: Microcap Speculators
Contact Person: Media Manager
Email: info@microcapspecualtors.com
Phone: 1-702-720-6310
Country: United States
Website: http://microcapspeculators.com/
SOURCE: ACR Communication, LLC
